MINI FUTURE SHORT - PFIZER INC | Market Closed - Euronext Paris 17:30:02 05/06/2024 BST | ||
| 1.265 EUR | 0.00% |
|
| Current month | -6.69% | ||
| 1 month | -14.92% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
PFIZER, INC.
Latest news about PFIZER, INC.
More news
| Date | Price | Change |
|---|---|---|
| 05/06/24 | 1.265 | 0.00% |
| 04/06/24 | 1.265 | -1.56% |
| 03/06/24 | 1.285 | -4.46% |
| 31/05/24 | 1.345 | -3.58% |
| 30/05/24 | 1.395 | -1.41% |
Real-time Euronext Paris
Last update June 05, 2024 at 05:30 pm
More quotesStatic data
| Product type | Knock-Out with Stop Loss |
|---|---|
| Buy / Sell | PUT |
| Underlying | PFIZER, INC. |
| Issuer | 
BNP Paribas
|
| 8YOLB | |
| ISIN | FRBNPP05OSW7 |
| Date issued | 23/05/2023 |
| Strike | 42.88 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 0.67 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 1.715 € |
|---|---|
| Lowest since issue | 0.355 € |
Company Profile
Pfizer, Inc. is the world's leading pharmaceutical group. Net sales break down by family of products as follows:
- primary care products (72.8%): medicines used in internal medicine, vaccines, medicines for the prevention and treatment of Covid-19, antivirals, mRNA-based products, etc.;
- specialty care products (13.8%): medicines used in immunology, in hospitals and for the treatment of rare diseases, anti-inflammatory medicines, etc.;
- oncology products (12.1%);
- other (1.3%).
At the end of 2022, the group had more than 35 manufacturing sites worldwide.
Net sales are distributed geographically as follows: the United States (42.3%), Europe (21.9%) and other (35.8%).
Sector
-
Consensus: Pfizer, Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
25
Last Close Price
29.49
USD
Average target price
31.92
USD
Spread / Average Target
+8.22%
- Stock Market
- Certificates
- 8YOLB Certificat